| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |